Everyone seems to think how undervalued IXC is .
And that may be the case long term IF the company can get the required results from any trial they may do .
The main issue for me atm is the lack of clarity , perhaps the company not anticipating FDA issues and no immediate plan B , time lines seem to have gone out the window .
Shareholders need more
There has been opportunity costs in having funds tied up here for shareholders and I believe it’s time that shareholders had some joy .
IXC promote the fact that they have money in the bank which is great but hope not leading to complacency
Ann: Appendix 4E and Annual Report, page-58
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.463M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125000 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.6¢ | 8450 | 1 |
View Market Depth
| Last trade - 16.12pm 11/10/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable